The European Patients Academy on Therapeutic Innovation (EUPATI) has launched a toolkit to provide information for anyone who is interested in learning more about the medicines research and development (R&D) process.

The press release below describes the context and development of the toolkit.
Additionally, you can access the ‘EUPATI Toolbox on Medicines R&D’ at  and discover more about the ‘EUPATI Toolbox on Medicines R&D’ by watching the video.

Eupati Press Release 

More than 100 topics in 7 languages for patient advocates to discover, adapt and share
Online information resource designed to enable more meaningful patient involvement  
Information and education to help engage patients and patient advocates

(27 January 2016-Europe) – The European Patients’ Academy (EUPATI) today announces the launch of its new online Toolbox on Medicines Research & Development. The toolbox is available to European patient groups, patient advocates and anyone who is interested in learning more about the medicines research and development (R&D) process. Users can acquire the knowledge to make a meaningful contribution to medicines development and to the broader dialogue around patient empowerment. This online educational resource allows users to freely discover, adapt, and share materials. 

“The toolbox is a comprehensive, self-explanatory, educational resource that has been built so that learnings on medicines R&D can be developed and shared by patient advocates. It is the result of a long-term, concerted effort by expert stakeholders including patients, researchers and academics.  Our vision is that thousands of patient advocates in Europe will leverage the toolbox to enable more meaningful patient involvement and partnership in medicines R&D. The toolbox is EUPATI’s second core product, after the Patient Expert Training Course, designed to support patients with information and knowledge,’’ says Jan Geissler, Director, European Patients‘ Academy. 

“I am happy and proud that after a long period of hard work we are able to give the public access to this unique toolbox on medicines R&D. Unique because it covers all relevant aspects of medicines R&D, unique because it will be a tool of great value for patient advocates to educate themselves and other patient advocates, and unique because it is the result of great cooperation, led by patients, between all stakeholder groups,” agrees Jytte Lyngvig, former Senior Vice President & Managing Director of DIA Europe, Middle East & Africa. DIA manages the creation and editing of all content online.
The online toolbox is available in seven languages (English, French, German, Spanish, Italian, Polish and Russian) and contains over 3000 expert materials on the ‘A-Z’ of medicines R&D. For example, content includes information-rich modules and best-in-class educational materials on discovery research, clinical development, regulatory affairs, medicinal safety, pharmacovigilance and the principles of health technology assessment. Users can access a wealth of fact sheets, graphics, slideshows, videos, recorded webinars, print-ready materials as well as a full glossary. European patient groups and patient advocates are invited to use the toolbox to discover the latest educational resources, to educate and train patient communities, and to identify opportunities on how to get involved in medicines R&D. 

“I see the toolbox as an important information gateway for patients and advocates to help them understand more about how medicines are developed and the type of involvement they can have in this process” according to Kay Warner, industry representative, EUPATI UK.

Irene Oldfather, Chair of EUPATI UK and Director and the ALLIANCE recognises that “Empowering patients and giving them a voice in their health and wellbeing is crucial. The Toolkit will be an effective way to give patients access to the kinds of information that will assist them to speak up and speak out in an informed way”. 
You can access the ‘EUPATI Toolbox on Medicines R&D’ at

Discover more about the ‘EUPATI Toolbox on Medicines R&D’ by watching the video

– The European Patients’ Academy on Therapeutic Innovation provides scientifically reliable, objective, comprehensive information to patients and the general public on the research and development process of medicines. It will increase the capacity of patients and the lay public to be effective advocates and advisors, e.g., in clinical trials, with regulatory authorities and in ethics committees. EUPATI is a team of 33 organisations, led by the European Patients’ Forum, made up of a unique combination of patient organisations, university and not-for-profit organisations expert in patient and public engagement, along with European pharmaceutical companies working in research. EUPATI wants to offer information and education that will help involve patients and patient advocates throughout the medicines research and development process.
EUPATI aims to make a visible difference to all stakeholders involved in medicines research and development, clarifying ways for a more meaningful involvement in areas like drug discovery, clinical trials planning and conduct, the assessment of safety of medicines, the balance of benefit and risk and health economics.
Find out more about the European Patients’ Academy, including our ethics and transparency policies, in seven languages, HERE

The “European Patients’ Academy on Therapeutic Innovation” project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334, resources of which are composed of financial contribution from the European Union‘s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.

@eupatients, @patientsinvolved
The EUPATI project receives support from the European Union (IMI JU) and EFPIA companies. Copyright EUPATI © 2016. All Rights Reserved.